
Profile
General Information
Bromfenac was cleared for marketing by the FDA on July 15, 1997. This provides an alternative to opioids for the management of acute pain. Bromfenac provides fast relief of acute pain without the side effects of opioid analgesics.
Side Effects
Possible adverse side effects include abdominal pain, headache, nausea, and vomiting.
Approval Date: 1997-07-01
Company Name: Duract, Wyeth-Ayerst Laboratories